MENU

SLRN Stock SLRN is expected to report earnings to fall -23% to -127 cents per share on June 12

A.I.dvisor
at Tickeron.com
Loading...
SLRN - ACELYRIN
ACELYRIN Earnings Graph
Q1'25
Est.
$-1.27
Q4'24
Beat
by $0.38
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.22
Q1'24
Beat
by $0.65
The last earnings report on December 31 showed earnings per share of -103 cents, beating the estimate of -141 cents. P/B Ratio (0.563) is normal, around the industry mean (16.715). P/E Ratio (0.000) is within average values for comparable stocks, (60.189). SLRN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.286). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (262.364). With 4.07M shares outstanding, the current market capitalization sits at 229.16M.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4149 Liberty Canyon Road
Phone
+1 805 730-0360
Employees
130
Web
https://www.acelyrin.com